Treatment for the myelodysplastic syndromes.
D002117:Calcitriol / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011379:Prognosis; D014212:Tretinoin / Q000627:therapeutic use
D003561:Cytarabine; D014212:Tretinoin; D002117:Calcitriol